Related Experiment Video
Updated: May 5, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Lamotrigine use in twelve patients with the Lennox-Gastaut Syndrome
1Epilepsy Unit, Westmead Hospital, Sydney, Australia.
Abstract:
This brief report describes the effects of lamotrigine on 12 patients with the Lennox-Gastaut Syndrome in an open, uncontrolled study. Three patients are seizure free and five others substantially improved. Seven of these eight patients have shown a marked improvement in quality of life. Lamotrigine is an extremely useful adjunct in the management of the Lennox-Gastaut Syndrome.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Epilepsy ll: Types
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

